ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00074750
Recruitment Status : Terminated (Slow accrual.)
First Posted : December 23, 2003
Last Update Posted : February 22, 2012
Sponsor:
Collaborator:
Wake Forest University
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2004
  Actual Study Completion Date : December 2004